Zobrazeno 1 - 10
of 148
pro vyhledávání: '"DC Doval"'
Autor:
Kumar Prabhash, DC Doval, Bharath Rangarajan, Naresh Somani, Aarohan Pruthi, Yulia Dyachkova, Tarun Puri
Publikováno v:
Cancer Research, Statistics, and Treatment. 4:634
Publikováno v:
Indian Journal of Medical Microbiology. 22:16-22
PURPOSE: To report a fatal case of disseminated trichosporonosis caused by Trichosporon asahii in a patient with acute myeloblastic leukemia (AML) and to present an update on systemic trichosporonosis with special reference to India. METHODS: The dia
Autor:
DC Doval
Publikováno v:
Asian Journal of Oncology, Vol 01, Iss 02, Pp 063-064 (2015)
Autor:
PM Parikh, S Gupta, B Parikh, BK Smruti, J Issrani, S Topiwala, C Goswami, GS Bhattacharya, T Sen, JS Sekhon, H Malhotra, S Nag, RT Chacko, KBabu Govind, T Raja, AK Vaid, DC Doval, PK Das
Publikováno v:
Indian Journal of Cancer. 48:158
Background: In order to document the understanding of current evidence for the management of triple negative breast cancer and application of this knowledge in daily practice, we conducted an interactive survey of practicing Indian oncologists. Mater
Autor:
Maurizio Scaltriti, José Antonio Jiménez, Maria Koehler, J. Baselga, Yuan Liu, Henry L. Gomez, DC Doval, Claudia Aura, Catherine E. Ellis, M Guix, Robert C. Gagnon
Publikováno v:
Cancer Research. 69:708
Abstract #708 Background: A subgroup of HER2 overexpressing tumors also express p95HER2, a truncated fragment of the HER2 receptor that lacks the extracellular domain and retains kinase activity. Tumors expressing p95HER2 have a worse clinical outcom
Autor:
K Prabhash, DC Doval
Publikováno v:
Indian Journal of Dermatology, Venereology and Leprology. 71:287
Publikováno v:
Europe PubMed Central
Oral Metastasis from a carcinoma of the urinary Bladder is extremely uncommon. Two cases of transitional cell carcinoma of the Bladder, presenting eighteen and ten months after initial diagnosis, one with soft tissue metastasis in the upper alveolus
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7d4897e772172d92027ff02b940deaed
http://europepmc.org/abstract/med/8063340
http://europepmc.org/abstract/med/8063340
Autor:
Bansal N; Rajiv Gandhi Cancer Institute, New Delhi, India. Electronic address: nitin.bansal3011@gmail.com., Goyal P; Rajiv Gandhi Cancer Institute, New Delhi, India. Electronic address: pankaj155@yahoo.com., Basu D; Rajiv Gandhi Cancer Institute, New Delhi, India. Electronic address: basu.dharmishtha@gmail.com., Batra U; Rajiv Gandhi Cancer Institute, New Delhi, India. Electronic address: ullasbatra@gmail.com., Sachdeva N; Rajiv Gandhi Cancer Institute, New Delhi, India. Electronic address: sacheva.neelam@rgcirc.org., Joga S; Rajiv Gandhi Cancer Institute, New Delhi, India. Electronic address: srujanajoga@gmail.com., Jain A; Rajiv Gandhi Cancer Institute, New Delhi, India. Electronic address: arpitjain8390@gmail.com., Doval DC; Rajiv Gandhi Cancer Institute, New Delhi, India. Electronic address: doval.dc@rgcirc.org.
Publikováno v:
Indian journal of medical microbiology [Indian J Med Microbiol] 2023 Sep-Oct; Vol. 45, pp. 100383. Date of Electronic Publication: 2023 May 23.
Autor:
Maheshwari U; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, India., Goyal P; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, India., Goel V; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, India., Patnaik N; Department of Pathology, Rajiv Gandhi Cancer Institute and Research Centre, India., Koyyala VPB; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, India., Chaudhari K; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, India., Doval DC; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, India., Talwar V; Department of Medical Oncology, Rajiv Gandhi Cancer Institute and Research Centre, India.
Publikováno v:
The Gulf journal of oncology [Gulf J Oncolog] 2023 May; Vol. 1 (42), pp. 40-46.
Autor:
Loi S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Karapetis CS; Flinders Medical Centre and Flinders University, Adelaide, Australia., McCarthy N; Icon Cancer Centre Wesley, Auchenflower, Queensland, Australia., Oakman C; Sunshine Hospital, Victoria, Australia., Redfern A; Fiona Stanley Hospital, Murdoch, Australia., White M; Monash Health, Clayton, Victoria, Australia., Khasraw M; Duke Cancer Institute, Durham, North Carolina, USA., Doval DC; Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India., Gore V; Sahyadri Super Specialty Hospital, Pune, Maharashtra, India., Alam M; Pfizer Australia, Sydney, Australia., Binko J; Pfizer Australia, Sydney, Australia., Lu DR; Pfizer Inc, San Diego, California, USA., Kim S; Pfizer Inc, San Diego, California, USA., Boyle F; Patricia Ritchie Centre for Cancer Care and Research, Mater Hospital, North Sydney, Australia.
Publikováno v:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2022 Dec; Vol. 18 (6), pp. 560-569. Date of Electronic Publication: 2021 Dec 14.